ImaginAb's Seed Round

ImaginAb raised a round of funding on , . Investors include Momentum Biosciences.

ImaginAb is redefining therapeutic management by harnessing the power of antibody technology for in vivo imaging. The company's antibody fragment platform yields actionable molecular information to gu…

Articles about ImaginAb's Seed Round: